Determination of a series of nonsteroidal anti-inflammatory drugs using the sensitized luminescence of lanthanides

被引：12

作者：

Egorova, A. V. ^{[1
]}

Anelchyk, A. V. ^{[2
]}

Leonenko, I. I. ^{[1
]}

Skripinets, Yu. V. ^{[1
]}

Antonovich, V. P. ^{[1
]}

机构：

[1] Natl Acad Sci Ukraine, Bogatsky Physicochem Inst, UA-65080 Odessa, Ukraine

[2] ODO INTERCHEM, UA-65080 Odessa, Ukraine

来源：

JOURNAL OF ANALYTICAL CHEMISTRY | 2015年 / 70卷 / 04期

关键词：

mixed ligand complexes; terbium; europium; sensitized luminescence; nonsteroidal anti-inflammatory drugs; TERBIUM; HPLC; COMPLEXES; NSAIDS; PLASMA; URINE; ACID;

D O I：

10.1134/S1061934815040048

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

The spectral-luminescent characteristics of a series of nonsteroidal anti-inflammatory drugs (NSAID) and their complexes with Eu(III) and Tb(III) have been studied. A possibility of NSAID determination using the sensitized luminescence of lanthanides has been shown. A synergistic effect of the impact of trioctylphosphine oxide (TOPO) and Triton X-100 on the luminescence intensity of mixed-ligand complexes La(III)-NSAID-TOPO in a micellar medium (Triton X-100), used as analytical forms, has been found. The limits of detection for NSAID in various dosage forms are from 0.012 to 2.0 mu g/mL.

引用

页码：440 / 449

页数：10

共 50 条

[41] Nonsteroidal Anti-Inflammatory Drugs: Adverse Effects and Their Prevention
Vonkeman, Harald E.
van de Laar, Mart A. F. J.
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2010, 39 (04) : 294 - 312
[42] The role of nonsteroidal anti-inflammatory drugs in pediatric patients
Dills, Robin
Anderson, Leigh A.
Pierce, Catherine A.
PHARMACOLOGICAL RESEARCH, 2012, 65 (01) : 5 - 8
[43] Risk of stroke associated with nonsteroidal anti-inflammatory drugs
Park, Ki
Bavry, Anthony A.
VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 25 - 32
[44] The use of nonsteroidal anti-inflammatory drugs in polymorbid pathology
Asfandiyarova, N. S.
Philippov, E., V
TERAPEVTICHESKII ARKHIV, 2020, 92 (01) : 82 - 88
[45] Nonsteroidal Anti-Inflammatory Drugs and Lower Gastrointestinal Complications
Lanas, Angel
Sopena, Federico
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2009, 38 (02) : 333 - +
[46] The problem of cardiac safety of nonsteroidal anti-inflammatory drugs
Shostak, N. A.
Klimenko, A. A.
Demidova, N. A.
Kondrashov, A. A.
TERAPEVTICHESKII ARKHIV, 2016, 88 (05) : 113 - 117
[47] Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
Bornebroek, Marjolijn
de Lau, Lonneke M. L.
Haag, Mendel D. M.
Koudstaal, Peter J.
Hofman, Albert
Stricker, Bruno H. C.
Breteler, Monique M. B.
NEUROEPIDEMIOLOGY, 2007, 28 (04) : 193 - 196
[48] Meloxicam: The golden mean of nonsteroidal anti-inflammatory drugs
Karateev, A. E.
TERAPEVTICHESKII ARKHIV, 2014, 86 (05) : 99 - +
[49] Use of nonsteroidal anti-inflammatory drugs in the older adult
Fowler, Terri O.
Durham, Catherine O.
Planton, Jonathan
Edlund, Barbara J.
JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2014, 26 (08) : 414 - 423
[50] Multiple cutaneous sensitization to nonsteroidal anti-inflammatory drugs
Gonzalo, MA
Revenga, F
DERMATOLOGY, 1996, 193 (01) : 59 - 60

← 1 2 3 4 5 →